Welcome to Santa Cruz Biotechnology!

TSPAN2 Antibody (Y-13): sc-241724

 |  Datasheet

(Based on data analysis)

  • TSPAN2 Antibody (Y-13) is a goat polyclonal IgG provided at 200 µg/ml
  • epitope mapping within an extracellular domain of TSPAN2 of human origin
  • recommended for detection of TSPAN2 of human origin by WB, IF and ELISA; non cross-reactive with other TSPAN family members; also reactive with additional species, including canine and porcine
  • blocking peptide, sc-241724 P
 

See additional TSPAN Antibodies including TSPAN, TSPAN1, TSPAN18, TSPAN2, TSPAN3, TSPAN6, TSPAN7, TSPAN8, TSPAN11 and TSPAN19.

Ordering InformationGene Info
Recommended Support Products:
(click button of application of choice)
WB   IF  
Set Currency

 Ordering Information
Product NameCatalog #UnitPriceQtyAdd 
TSPAN2 Antibody (Y-13) sc-241724 200 µg/ml $279
TSPAN2 (Y-13) P sc-241724 P
(peptide)
100 µg/0.5 ml $61
 
Species Gene Name Gene ID Chromosome Location Isoform (mRNA) Accession # Protein Accession # OMIM™ Number
Human TSPAN2 10100 1p13.2 NM_005725 O60636
n/a
 


Chromosome 1 is the largest human chromosome spanning about 260 million base pairs and making up 8% of the human genome. There are about 3,000 genes on chromosome 1, and considering the great number of genes there are also a large number of diseases associated with chromosome 1. Notably, the rare aging disease Hutchinson-Gilford progeria is associated with the LMNA gene which encodes lamin A. When defective, the LMNA gene product can build up in the nucleus and cause characteristic nuclear blebs. The mechanism of rapidly enhanced aging is unclear and is a topic of continuing exploration. The MUTYH gene is located on chromosome 1 and is partially responsible for familial adenomatous polyposis. Stickler syndrome, Parkinsons, Gaucher disease and Usher syndrome are also associated with chromosome 1. A breakpoint has been identified in 1q which disrupts the DISC1 gene and is linked to schizophrenia. Aberrations in chromosome 1 are found in a variety of cancers including head and neck cancer, malignant melanoma and multiple myeloma.